Search results

BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins. It is a cutting-edge and mature solution for oral formulations not only for peptides, but also small molecules, novel protein scaffolds, nucleotides, domain antibodies.

Qanatpharma (QP) is a Swiss clinical-stage biotech pioneering resistance artery medicine. Our Arteriome platform combines vascular biology, functional phenotyping and AI to discover novel drug targets and develop therapeutics for cardiovascular and neurological diseases.